市場調査レポート
商品コード
1481417
止血製品の世界市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別- 産業予測、2024年~2031年Global Hemostasis Products Market Size, Share, Growth Analysis, By Product(Topical Hemostasis Products, Infusible Hemostasis Products), By Application(Trauma, Surgery), By End-user(Hospitals, Clinics) - Industry Forecast 2024-2031 |
止血製品の世界市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別- 産業予測、2024年~2031年 |
出版日: 2024年05月17日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
|
止血製品の世界市場規模は2022年に16億米ドルと評価され、2023年の16億9,000万米ドルから2031年には25億9,000万米ドルに成長し、予測期間(2024年~2031年)のCAGRは5.5%で成長する見通しです。
止血剤市場は、医療技術の向上と意識の高まりにより、世界規模で着実に拡大しています。これらの医薬品は、手術後や外傷後の止血だけでなく、さまざまな出血問題の管理にも不可欠です。止血剤市場は、人口の高齢化、慢性疾患の増加、手術件数の増加によって牽引されています。また、発展途上国におけるヘルスケア施設の利用しやすさも、業界の拡大を後押ししています。さらに、継続的な研究開発努力により、新しい止血製品が発売され、その有効性と安全性が高まっています。しかし、これらの製品は高価であり、規制上の障害もあるため、業界の拡大が阻まれる可能性があります。このような障害にもかかわらず、世界の止血材市場は、ヘルスケアの基準や技術が進歩するにつれて拡大すると予想されます。
Global Hemostasis Products Market size was valued at USD 1.60 billion in 2022 and is poised to grow from USD 1.69 billion in 2023 to USD 2.59 billion by 2031, growing at a CAGR of 5.5% during the forecast period (2024-2031).
The market for hemostasis products is expanding steadily on a global scale as a result of rising awareness and improvements in medical technology. These medicines are essential for managing a variety of bleeding problems as well as for stopping bleeding after surgery and trauma cases. The market for hemostasis products is being driven by an aging population, an increase in chronic diseases, and an increase in surgeries. The growing accessibility of healthcare facilities in developing nations is also fostering industry expansion. In addition, continuous R&D endeavors are resulting in the launch of novel hemostasis products, augmenting their effectiveness and safety. The expensive cost of these items and regulatory obstacles, however, may prevent the industry from expanding. Notwithstanding these obstacles, the market for hemostasis products worldwide is expected to grow as healthcare standards and technologies advance.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hemostasis Products Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the Market size includes the following details: The key players in the Market were identified through secondary research, and their Market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top Market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Hemostasis Products Market Segmental Analysis
The global hemostasis products market is segmented on the basis of product, application, end-user, and region. Based on product, the market is segmented as Topical Hemostasis Product, Infusible Hemostasis Products, and Advanced Hemostasis Products. On the basis of application, the market is segmented into Trauma, Surgery, Hemophilia, Myocardial Infarction. Based on the end-user, it is segregated into hospitals, clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Hemostasis Products Market
The treatment of bleeding problems and surgical operations are being significantly improved by innovations like the development of more environmentally friendly and safe hemostasis products, in addition to hemostatic agents and devices. These upgrades enhance patient outcomes and put pressure on a rise in the market.
Restraints in the Global Hemostasis Products Market
One of the most notable commercial constraints is the high price of hemostasis products. These products may be expensive, which limits their availability to patients in some areas and healthcare facilities with limited funding. The cost factor may prevent the widespread use of better hemostasis solutions, limiting their market penetration and possibly impairing patient care.
Market Trends of the Global Hemostasis Products Market
Both patients and healthcare organizations are looking for less intrusive ways to treat bleeding problems and surgical procedures. This movement makes use of the advancements in progressive hemostasis products and methods, which lessen tissue damage, speed up repair, and improve average patient outcomes. Due to its potential to improve patient comfort and reduce hospital stays, minimally invasive hemostasis techniques are gaining popularity. This trend is in line with the healthcare industry's emphasis on value-based treatment.